Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 9937159
Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
granted -
US 9938500
Hemangio-colony forming cells
granted -
US 9938516
Non-natural amino acid tRNA synthetases for para-methylazido-L-phenylalanine
granted -
US 9938589
Compositions and methods for detecting human pegivirus 2 (HPgV-2)
granted -
US 9937156
Modulation of MRTF-A activity in pathologic fibrosis and wound healing
granted -
US 9937141
Carcinoma diagnosis and treatment, based on ODC1 genotype
granted -
US 9937155
Methods of use for trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors
granted -
US 9937191
Inhibition of HIV infection through chemoprophylaxis
granted -
US 9938339
Method for treating an eye disease or disorder by administering an antibody that binds angiopoietin-2
granted -
US 9938270
Mono-phosphate salt of 6-fluoro-2-[4-(pyridin-2-yl)but-3-yn-1-yl]imidazo[1,2A]pyridine (dipraglurant) and polymorphs thereof as negative allosteric modulator of MGLU5 receptor
granted -
US 9937256
Hydrogels for delivery of therapeutic compounds
granted -
US 9938345
Human antibodies to PD-L1
granted -
US 9938526
Manganese ion coated nanoparticles for delivery of compositions into the central nervous system by nasal insufflation
granted -
US 9938582
Recurrent gene fusions in prostate cancer
granted -
US 9931311
Treating critically ill patients with intravenous ibuprofen
granted -
US 9931333
Compositions and methods for treating or preventing atrial fibrillation
granted -
US 9931389
Genetic attenuation of plasmodium by B9 gene disruption
granted -
US 9932322
Method for producing sulfonyl chloride compound
granted -
US 9932593
Compositions and methods for inhibiting expression of CD274/PD-L1 gene
granted -
US 9932589
EML4-ALK fusion gene
granted -
US 9932587
Methods of identifying and treating poor prognosis cancers
granted -
US 9932584
Interfering RNA delivery system and uses thereof
granted -
US 9932581
Compositions and methods for modulating apolipoprotein C-III expression
granted -
US 9932580
Compositions and methods for modulating HBV expression
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.